Patents Assigned to Orphan Medical, Inc., A Minnesota Corporation
  • Publication number: 20030125385
    Abstract: Disclosed are formulations of gamma-hydroxybutyrate in an aqueous medium that are resistant to microbial growth. Also disclosed are formulations of gamma-hydroxybutyrate that are also resistant to the conversion into GBL. Disclosed are methods to treat sleep disorders, including narcolepsy, with these stable formulations of GHB. The present invention also provides methods to treat alcohol and opiate withdrawal, reduced levels of growth hormone, increased intracranial pressure, and physical pain in a patient.
    Type: Application
    Filed: July 11, 2002
    Publication date: July 3, 2003
    Applicant: Orphan Medical, Inc., A Minnesota Corporation
    Inventors: Harry Cook, Martha Hamilton, Douglas Danielson, Colette Goderstad, Dayton Reardan